Monitoring host–pathogen interactions using chemical proteomics-Reference-Cited by-同舟云学术

Monitoring host–pathogen interactions using chemical proteomics

Published:2024 Issue: Volume: Page:
ISSN:2633-0679
Container-title:RSC Chemical Biology
language:en
Short-container-title:RSC Chem. Biol.

Author:

Weigert Muñoz Angela¹^ORCID,Zhao Weining²^ORCID,Sieber Stephan A.¹³^ORCID

Affiliation:

1. Center for Functional Protein Assemblies, Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Ernst-Otto-Fischer-Straße 8, D-85748 Garching, Germany

2. College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China

3. Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany

Abstract

We review how chemical proteomic tools have been used to elucidate biological processes at the interface of bacteria and eukaryotic hosts, which can be important in the establishment of pathogenicity.

Funder

Studienstiftung des Deutschen Volkes

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Biology,Biochemistry,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/CB/D3CB00135K

Reference205 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

2. Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis

3. Antibiotics for Emerging Pathogens

4. The Science of Antibiotic Discovery

5. Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity-based protein profiling in drug/pesticide discovery: Recent advances in target identification of antibacterial compounds;Bioorganic Chemistry;2024-10

2. Return of the forgotten nightmare: Bordetella pertussis uses a more negative Gibbs energy of metabolism to outcompete its host organism;Microbial Risk Analysis;2024-04

3. Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications;Pharmaceuticals;2024-03-28